Department of Pharmacology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Am J Respir Crit Care Med. 2010 Nov 1;182(9):1184-94. doi: 10.1164/rccm.201001-0047OC. Epub 2010 Jul 9.
Hypoventilation is typically treated with positive pressure ventilation or, in extreme cases, by phrenic nerve stimulation. This preclinical study explores whether direct stimulation of central chemoreceptors could be used as an alternative method to stimulate breathing.
To determine whether activation of the retrotrapezoid nucleus (RTN), which is located in the rostral ventrolateral medulla (RVLM), stimulates breathing with appropriate selectivity.
A lentivirus was used to induce expression of the photoactivatable cationic channel channelrhodopsin-2 (ChR2) by RVLM Phox2b-containing neurons, a population that consists of central chemoreceptors (the ccRTN neurons) and blood pressure (BP)-regulating neurons (the C1 cells). The transfected neurons were activated with pulses of laser light. Respiratory effects were measured by plethysmography or diaphragmatic EMG recording and cardiovascular effects by monitoring BP, renal sympathetic nerve discharge, and the baroreflex.
The RVLM contained 600 to 900 ChR2-transfected neurons (63% C1, 37% ccRTN). RVLM photostimulation significantly increased breathing rate (+42%), tidal volume (21%), minute volume (68%), and peak expiratory flow (48%). Photostimulation increased diaphragm EMG amplitude (19%) and frequency (21%). Photostimulation increased BP (4 mmHg) and renal sympathetic nerve discharge (43%) while decreasing heart rate (15 bpm).
Photostimulation of ChR2-transfected RVLM Phox2b neurons produces a vigorous stimulation of breathing accompanied by a small sympathetically mediated increase in BP. These results demonstrate that breathing can be relatively selectively activated in resting unanesthetized mammals via optogenetic manipulation of RVLM neurons presumed to be central chemoreceptors. This methodology could perhaps be used in the future to enhance respiration in humans.
通气不足通常采用正压通气治疗,在极端情况下,采用膈神经刺激。本临床前研究旨在探索直接刺激中枢化学感受器是否可用作刺激呼吸的替代方法。
确定位于延髓腹外侧头端(RVLM)的延髓后外侧核(RTN)的激活是否可以选择性地刺激呼吸。
使用慢病毒诱导 RVLM Phox2b 神经元表达光激活阳离子通道通道视紫红质-2(ChR2),该神经元群由中枢化学感受器(ccRTN 神经元)和调节血压(BP)的神经元(C1 细胞)组成。转染神经元用激光脉冲激活。呼吸效应通过 plethysmography 或膈肌 EMG 记录测量,心血管效应通过监测 BP、肾交感神经放电和压力反射测量。
RVLM 包含 600 到 900 个 ChR2 转染神经元(63% C1,37% ccRTN)。RVLM 光刺激显著增加呼吸频率(+42%)、潮气量(21%)、分钟通气量(68%)和呼气峰流速(48%)。光刺激增加膈肌 EMG 幅度(19%)和频率(21%)。光刺激增加 BP(4mmHg)和肾交感神经放电(43%),同时降低心率(15 bpm)。
RVLM Phox2b 神经元 ChR2 转染的光刺激产生强烈的呼吸刺激,同时伴有交感神经介导的 BP 适度增加。这些结果表明,通过 RVLM 神经元的光遗传学操作(假定为中枢化学感受器),可以在休息的未麻醉哺乳动物中相对选择性地激活呼吸。这种方法将来也许可以用于增强人类的呼吸。